Article Text

AB0844 Detection of low Levels of Vitamin D or Free Testosterone in Patients Receiving Prednisone for A Rheumatic Disease
  1. M. Imran1,
  2. H. Singh2,
  3. B. Lukert2,
  4. H. Lindsley2
  1. 1Division of Allergy, Clinical Immunology, & Rheumatology
  2. 2University of Kansas Medical Center, Kansas City, United States


Objectives The purpose of this cross-sectional study was to determine the prevalence of vitamin D insufficiency in males and females and testosterone deficiency in males, who have an increased risk for osteoporosis due to prednisone therapy. Mild to moderate vitamin D insufficiency causes osteoporosis. Twenty five-hydroxy vitamin D <32 ng/ml leads to reduce calcium absorption, higher concentration of parathyroid hormone, and increased bone resorption1.

Methods Blood samples were obtained from rheumatology practices, (four community-based and one university-based) from men and women with a rheumatic disease. The patients were >40 years old and were taking at least 5 mg of prednisone for at least the past 30 days. Serum levels of 25-hydroxy vitamin D (25-OHD), free testosterone in males (FT-M) only, and osteocalcin (OC) were measured in 44 individuals. Non –parametric analysis of the data was done as shown in Table 1.

Table 1

ResultsTwenty nine patients (65%) were found to have 25-OHD levels <32; of these only 41% were on over the counter (OTC) vitamin D as opposed to 80% with 25-OHD >32. Fourteen males (58%) had testosterone deficiency (<1 ng/dl). Increasing prednisone dose correlated with lower mean OC values (P=0.003).

Conclusions Our sample revealed a high prevalence of vitamin D insufficiency and underutilization of OTC vitamin D in rheumatology practices. There was an encouraging trend towards higher vitamin D levels with use of OTC vitamin D. A large number of male patients were noted to have low testosterone levels. In patients with a rheumatic disease on prednisone therapy, there appears to be a high incidence of vitamin D insufficiency and testosterone (in males) deficiency. Routine screening for 25-OHD and free testosterone (in males) should be utilized to reduce the risk of osteoporosis.


  1. Luckeyet al. J ClinEndocMetab 2003

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.2623

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.